We spoke to Spencer Hawkswell, Executive Director of TheraPsil: a non-profit advocacy group seeking to facilitate legal access to psilocybin therapy for terminally-ill patients.
In this interview, Spencer gives a detailed overview of TheraPsil’s evidence-based, legal, and moral reasoning behind their push for access to the substance.
Share this post
